COVID-19

May 6, 2021

VUMC to lead national study to treat severe COVID complications

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

By Bill Snyder
Jeff Balser, MD, PhD, discusses VUMC’s commitment to community during this week’s Leadership Assembly.
May 6, 2021

Flexibility, trust: Takeaways from Leadership Assembly

The flexibility and adaptability of Vanderbilt University Medical Center has been center stage as the pressures of COVID-19 and ongoing strategic imperatives have transformed how and where care is delivered.

By Holly Fletcher
April 29, 2021

VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

By Paul Govern
April 23, 2021

Vaccinated patients avoiding hospital stays as pandemic rages on

Vanderbilt University Medical Center (VUMC) is reporting only four persons who have been fully vaccinated against COVID-19 have been diagnosed with COVID during an acute care hospitalization at its facilities over the past four months.

By Paul Govern
April 19, 2021

VUMC aids national effort to repurpose drugs for COVID-19

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

By Bill Snyder
April 19, 2021

Extracting accurate COVID data from scanned forms

A switch to paper forms during the COVID-19 pandemic might have hobbled research, but using software with a novel user interface made it possible to accurately extract information from scanned forms.

By Paul Govern
April 15, 2021

Team analyzed clinical notes to identify COVID symptoms

At the start of the COVID-19 pandemic, public health authorities first had to identify and draw attention to common signs and symptoms of the disease.
By Paul Govern
April 12, 2021

VUMC team’s COVID-19 research featured on “60 Minutes”

James Crowe, MD, and members of his lab at Vanderbilt University Medical Center who have pioneered rapid development of monoclonal antibody treatments for life-threatening viral diseases including COVID-19, were featured Sunday on a CBS News 60 Minutes segment titled “The Last Pandemic.”
By Bill Snyder
April 12, 2021

Crowe receives SEC Faculty Achievement Award

James Crowe Jr., MD, a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award.
By VUMC News and Communications
April 8, 2021

VUMC creates new Adult Post-acute COVID Clinic

On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.
By Paul Govern
April 7, 2021

COVID-19 lessons: VUMC, other hospital leaders pinpoint opportunities in National Academy Review

The versatility of health systems in the national COVID-19 response underscore the challenges and opportunities for leaders to strengthen and design systems to better care for communities and respond to ever-changing needs, top health care delivery system leaders outline in a discussion paper for the National Academy of Medicine (NAM).
By Holly Fletcher
April 6, 2021

U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC

The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.
By Bill Snyder
April 2, 2021

Investigational vaccine to be tested against COVID-19 variant

Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.
By Bill Snyder
1 … 13 14 15 16 17 … 40